167 clinical trials matched your search for Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Cancer A Study for Children with Acute Lymphoblastic Leukemia Using Study Drug Carfilzomib Nobuko Hijiya, MD
Cancer A Study for Patients with Advanced Melanoma, Solid Tumors or Lymphoma Using Study Drug Pembrolizumab Nobuko Hijiya, MD
Cancer Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Nobuko Hijiya, MD
Cancer Study of Focused Ultrasound (FUS) with DEFINITY Microbubbles in Children and Young Adults with Progressive Diffuse Midline Glioma (DMG) Cheng-Chia Wu, MD
Childhood Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Childhood Leukemia Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) Nobuko Hijiya, MD
Sarcoma A Study for Patients with Malignant Peripheral Nerve Sheath Tumors Using Study Drugs PLX3397 and Sirolimus Gulam Manji, MD, PhD
Cancer Collecting and growing patient tumor and blood cells from extra tissue to learn about cancer and test new drugs Bret Taback, MD
Pancreatic Cancer The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) Fay Kastrinos, MD
Cancer Identification of Targets for Cancer Treatment Andrea Califano, PhD
Lymphoma Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease Ran Reshef, MD
Breast Cancer Study to Predict Your Therapeutic Response (I-SPY 2 Trial) Meghna Trivedi, MD
Solid Tumors Study of Drug Alone and In Combination with Nivolumab in Advanced Solid Tumors Brian Henick, MD
Pancreatic Cancer Study of Multiple Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) Gulam Manji, MD, PhD
Cancer Early Onset Malignancies Initiative (EOMI) Bret Taback, MD
Cancer Study of Atezolizumab in Alveolar Soft Part Sarcoma Prabhjot Mundi, MD
Liver Cancer A 5-Year Study of the Natural History and Management of Patients with Hepatocellular Carcioma (A Type of Liver Cancer) Elizabeth Verna, MD
Pancreatic Cancer Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery Susan Bates, MD
Gynecologic Cancer Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer June Hou, MD
Cancer Clinical Trial Screening Tool to Address Cancer Health Disparities Katherine Crew, MD
Kidney Cancer Study of Experimental Drug (Axitinib) in Patients with Metastatic Pheochromocytoma (PCC) or Paraganglioma Antonio Fojo, MD, PhD
Cancer A Study of MS-553 in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Nicole Lamanna, MD
Prostate Cancer IRONMAN: International Registry for Men with Advanced Prostate Cancer Mark Stein, MD
Breast Cancer Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer Melissa Accordino, MD
Kidney Cancer Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma Karie D. Runcie, MD
Multiple Myeloma First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma Suzanne Lentzsch, MD
Bladder Cancer ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the Bladder Christopher Anderson, MD
Solid Tumors Study of ASTX295 in Patients With Solid Tumors Fabio Iwamoto, MD
Cancer Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) Mark Stein, MD
Brain Tumors Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Cancer Study of IDE196 in Patients with Solid Tumors Shaheer Khan, DO
Cancer Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors Brian Henick, MD
Leukemia Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 Nobuko Hijiya, MD
Cancer Study of AMG510 in Subjects with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Breast Cancer Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients Dawn Hershman, MD
Cancer Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia Ran Reshef, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Lung Cancer Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Testing Whether the Use of Brain Scans Alone vs. Brain Scans Plus Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer Simon Cheng, MD, PhD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Catherine Shu, MD
Breast Cancer MiChoice: Making Informed Choices on Incorporating Chemoprevention Into Care Katherine Crew, MD
Sarcoma Study of Belinostat and Guadecitabine for Treatment of Chondrosarcoma Shaheer Khan, DO
Cancer Study of ST101 in Patients with Advanced Solid Tumors Fabio Iwamoto, MD
Pancreatic Cancer Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma Gulam Manji, MD, PhD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Kidney Cancer Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition Mark Stein, MD
Lung Cancer Study of Combining Osimertinib with and without Ramucirumab in Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Brain Tumors Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for Treatment of Newly Diagnosed Glioblastoma Fabio Iwamoto, MD
Squamous Cell Carcinoma Study of Ruxolitinib in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma Alexander Wei, MD
Cancer A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors Matthew Ingham, MD
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors Shaheer Khan, DO
Lung Cancer Tomivosertib With Anti-PD-(L)1 in Subjects With Non-Small Cell Lung Cancer (NSCLC) Brian Henick, MD
Cancer Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Brian Henick, MD
Autoimmune Disorders Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Brian Henick, MD
Brain Tumors ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma Brian Gill, MD
Pancreatic Cancer Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) Susan Bates, MD
Lung Cancer Study of Osimertinib (TAGRISSOTM) in Non-Small Cell Lung Cancer (NeoADAURA) Patients Catherine Shu, MD
Melanoma Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease Alexander Wei, MD
Cancer Study of AB928 in Combination with Other Therapies for Patients with Metastatic Colon Cancer (mCRC) Gulam Manji, MD, PhD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer Mark Stein, MD
Cancer Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer David Horowitz, MD
Prostate Cancer Study of ADXS-504 in Patients with Prostate Cancer Mark Stein, MD
Breast Cancer Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors Dawn Hershman, MD
Lung Cancer Study of Atezolizumab and Tiragolumab Alone or in Combination with Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Leukemia Study of BGB-11417 in Patients with Leukemia Nicole Lamanna, MD
Lung Cancer Study in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) whose Disease has Gotten Worse After Osermitinib Treatment Catherine Shu, MD
Gastrointestinal Study of RO7198457 for Patients Who Have Had Surgery for Stage II and Stage III Colon Cancer Yoanna Pumpalova, MD
Breast Cancer Study of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple-Negative Breast Cancer Meghna Trivedi, MD
Cancer Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer Benjamin Herzberg, MD
Pancreatic Cancer Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer Susan Bates, MD
Brain Cancer Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM Andrew Lassman, MD
Brain Cancer Study of Tumor Treating Fields (Optune, 200kHz) with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Fabio Iwamoto, MD
Brain Cancer ImmuneSense Study: IGV-001 in Newly Diagnosed Patients With Glioblastoma Brian Gill, MD
Breast Cancer Decreasing Chemotherapy for HER2 Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy Julia McGuinness, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Lung Cancer Study of Pembrolizumab Alone or in Combination with Chemotherapy in Older Patients with Non-Small Cell Lung Cancer Catherine Shu, MD
Lung Cancer Liver-Directed Radiotherapy Along with Chemotherapy for Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC) and Liver Metastases Brian Henick, MD
Breast Cancer Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer Julia McGuinness, MD
Depression Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer John Markowitz, MD
Leukemia Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) Ran Reshef, MD
Brain Cancer Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Brain Tumors Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) Fabio Iwamoto, MD
Lung Cancer Study of Berzosertib Compared to Chemotherapy for Patients with Non-Small Cell Lung Cancer Benjamin Herzberg, MD
Breast Cancer Intervention to Improve Medication Scheduling for Patients with Breast Cancer Dawn Hershman, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Shaheer Khan, DO
Breast Cancer Study of RLY-2608 in Patients with Breast Cancer Julia McGuinness, MD
Melanoma Study of ALKS 4230 in Patients with Previously Treated Advanced Melanoma Benjamin Izar, MD
Prostate Cancer Study of XmAb20717 Alone or in Combination with Chemotherapy in Patients with Prostate Cancer Mark Stein, MD
Brain Cancer Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Brain Tumors Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) Fabio Iwamoto, MD
Breast Cancer Study of Radiation Therapy Alone or in Combination With Olaparib for Patients with Inflammatory Breast Cancer (IBC) Eileen Connolly, MD, PhD
Sarcoma Study of INBRX 109 in Patients with Metastatic or Inoperable Chondrosarcoma Shaheer Khan, DO
Cancer Study of RP-6306 in Combination with FOLFIRI in Patients with Advanced Solid Tumors (Colon, Esophageal, or GI Cancer) Ryan Moy, MD
Prostate Cancer Study of Cabozantinib in Patients with Prostate Cancer who Previously Received Anti-Androgen Therapy Mark Stein, MD
Lymphoma Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) Jennifer Amengual, MD
Lymphoma Study of TAK-007 in Patients with Non-Hodgkin Lymphoma Ran Reshef, MD
Breast Cancer Study of GLSI-100 in Female Patients with Breast Cancer Julia McGuinness, MD
Cancer Study of BT7480 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Lymphoma Study of Duvelisib or Azacitidine in Addition to Chemotherapy in Patients with Peripheral T-Cell Lymphoma (PTCL) Jennifer Amengual, MD
Cancer Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors Benjamin Izar, MD
Sarcoma Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma Brian Henick, MD
Breast Cancer Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation Katherine Crew, MD
Gastrointestinal Study of Pembrolizumab Alone or in Combination with Encorafenib and Cetuximab in Patients with Colon Cancer Yoanna Pumpalova, MD
Lymphoma Study of Lenalidomide in Combination with Chemotherapy in Patients with HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL) Jennifer Amengual, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Melanoma Study of DYP688 in Patients with Melanoma Shaheer Khan, DO
Cancer Study of E-602 Alone or in Combination with Libtayo (Cemiplimab) in Patients with Advanced Cancer Brian Henick, MD
Gastrointestinal Study of Domvanalimab and Zimberelimab Alone or in Combination with Chemotherapy in Patients with Upper Gastrointestinal Cancers (UGI) Ryan Moy, MD
Lymphoma Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Follicular Lymphoma Ran Reshef, MD
Prostate Cancer Study of CC-94676 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Karie D. Runcie, MD
Multiple Myeloma Study of STI-6129 in Patients with Relapse/Refractory Multiple Myeloma (RRMM) Rajshekhar Chakraborty, MD
Skin Cancer Study of RP1 in Organ Transplant Patients with Skin Cancer Shaheer Khan, DO
Sarcoma Study of Drug - CFT8634 in Patients with Synovial Sarcoma or SMARCB1-Null Tumors Shaheer Khan, DO
Pancreatic Cancer Study of Drug - SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) Gulam Manji, MD, PhD
Breast Cancer Study of Drug - LY3484356 in Patients with Breast Cancer (ER+, HER2-) Meghna Trivedi, MD
Sarcoma Study of Unesbulin in Patients with Leiomyosarcoma (LMS) Prabhjot Mundi, MD
Leukemia Study of Magrolimab in Combination with Chemotherapy in Patients with Acute Myeloid Leukemia (AML) Joseph Jurcic, MD
Breast Cancer Study of Sacituzumab Govitecan (TRODELVY) in Patients with Triple-Negative Breast Cancer (TNBC) Meghna Trivedi, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Prostate Cancer Study of JNJ-78278343 in Patients with Advanced Prostate Cancer Mark Stein, MD
Leukemia Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia Ran Reshef, MD
Lymphoma Study of STK-009 in Combination with SYNCAR-001 in Patients with Lymphoma or Leukemia Ran Reshef, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Breast Cancer Study of Sacituzumab Govitecan in Combination with Pembrolizumab vs. Chemotherapy in Patients with Advanced Triple-Negative Breast Cancer Meghna Trivedi, MD
Prostate Cancer Study of Lutetium-177 PSMA I&T in Patients with Castration-Resistant Prostate Cancer Mark Stein, MD
Cancer Study of Gavo-Cel Alone or in Combination with Nivolumab or Ipilimumab in Patients with Advanced Cancer Ran Reshef, MD
Lung Cancer ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC) Brian Henick, MD
Prostate Cancer Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer Mark Stein, MD
Healthy Volunteers Columbia University Biobank at New York Presbyterian (CUB-NYP) Muredach Reilly, MD
Brain Cancer Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Brain Tumors Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) Fabio Iwamoto, MD
Lung Cancer Study of Savolitinib in Combination with Osimertinib vs. Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Lung Cancer Study of Patritumab Deruxtecan in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer (NSCLC) Catherine Shu, MD
Brain Cancer Study of DSP-0390 in Patients with Recurrent High-Grade Glioma Mary Welch, MD
Brain Tumors Study of DSP-0390 in Patients with Recurrent High-Grade Glioma Mary Welch, MD
Prostate Cancer Study of VTP-850 in Male Patients with Prostate Cancer Whose Prostate-Specific Antigen (PSA) Levels Have Risen Mark Stein, MD
Gynecologic Cancer Study of SL-172154 in Combination with PLD or MIRV in Patients with Ovarian Cancer June Hou, MD
Gastrointestinal Study of DKN-01 in Combination with Tislelizumab & Chemotherapy in Patients with Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer Ryan Moy, MD
Melanoma Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma Benjamin Izar, MD
Leukemia Study of SEA-CD70 in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Joseph Jurcic, MD
Gynecologic Cancer Study of Upifitamab Rilsodotin (XMT-1536) in Patients with Recurrent Ovarian Cancer Jason Wright, MD
Cancer Study of ASKG915 in Patients with Advanced Solid Tumors Mark Stein, MD
Breast Cancer Study of Breast Cancer in Black Women Lauren Houghton, PhD
Breast Cancer Study of Breast Cancer in Black Women - Healthy Controls Lauren Houghton, PhD
Cancer Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors Karie D. Runcie, MD
Gynecologic Cancer Study of XmAb20717 in Patients with Gynecological Cancer (Cervical, Ovarian, or Endometrial) June Hou, MD
Cancer Study of MRT-2359 in Patients with Solid Tumors Benjamin Herzberg, MD
Gynecologic Cancer Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC) Jason Wright, MD
Cancer Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation Benjamin Herzberg, MD
Lymphoma Study of ONO-4685 in Patients with T-Cell Lymphoma Barbara Pro, MD
Gynecologic Cancer Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations Jason Wright, MD
Gynecologic Cancer Study of Abemaciclib in Combination with Letrozole in Women with Endometrial Cancer Jason Wright, MD
Gynecologic Cancer Study of MORAb-202 in Women with Ovarian, Fallopian, or Primary Peritoneal Cancer (PPC) June Hou, MD
Gynecologic Cancer Study of ZN-c3 in Patients with Solid Tumors with MRE11, RAD50, NBN, or CCNE1 Gene Mutations June Hou, MD
Lymphoma Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma Ran Reshef, MD
Breast Cancer Tele-IPT vs. Tele-Pharmacotherapy for Depression in Patients with Non-Metastatic Breast Cancer John Markowitz, MD
Cancer Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma June Hou, MD
Lymphoma Study of LOXO-305 in Patients with Mantle Cell Lymphoma (MCL) Andrew Lipsky, MD
Cancer ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma Ran Reshef, MD
Multiple Myeloma Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis Rajshekhar Chakraborty, MD
Endocrine & Metabolic Disease Temporary Insulin Resistance Joshua Cook, MD, PhD
Diabetes Temporary Insulin Resistance Joshua Cook, MD, PhD
Healthy Volunteers Temporary Insulin Resistance Joshua Cook, MD, PhD